The FDA advisory committee vote on tofersen Wednesday was an exciting and critical moment in the ALS community’s efforts to find new treatments and cures. The committee voted unanimously to recommend accelerated approval of the new treatment.
We thank the FDA Advisory Committee for their clear and compelling recommendation that tofersen be approved under the accelerated approval pathway. We urge the FDA to swiftly approve this urgently needed new treatment. Americans living with this rare and aggressive genetic form of ALS cannot wait.
The West Palm Beach VA ALS Clinic in West Palm Beach, Florida provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The MDA/ALS Care Center at Integris Southwest Medical Center in Oklahoma City, Oklahoma provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The Catalyst NeuroMedical ALS Multidisciplinary Clinic in Redding, California provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The MDA/ALS Clinic at University of Mississippi Medical Center in Jackson, Mississippi provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The East Tennessee Center for ALS Care in Knoxville, Tennessee provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The Gary E. Shealy Memorial ALS Clinic at Eastern Tennessee State University in Johnson City, Tennessee provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.